ODI Pharma AB (publ) (NGM:ODI)

Market Cap	36.60M
Revenue (ttm)	18.73M
Net Income (ttm)	-4.03M
Shares Out	15.92M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,208
Average Volume	2,877
Open	2.440
Previous Close	2.500
Day's Range	2.300 - 2.560
52-Week Range	2.080 - 8.150
Beta	0.61
RSI	30.60
Earnings Date	Feb 21, 2025

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2018
• Employees: 1
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: ODI

Financial Performance

In 2024, ODI Pharma AB's revenue was 22.29 million, an increase of 15880.34% compared to the previous year's 139,457. Losses were -568,059, -91.77% less than in 2023.